FI963194A0 - Syklinen tulehduksenvastainen heptapeptidi - Google Patents

Syklinen tulehduksenvastainen heptapeptidi

Info

Publication number
FI963194A0
FI963194A0 FI963194A FI963194A FI963194A0 FI 963194 A0 FI963194 A0 FI 963194A0 FI 963194 A FI963194 A FI 963194A FI 963194 A FI963194 A FI 963194A FI 963194 A0 FI963194 A0 FI 963194A0
Authority
FI
Finland
Prior art keywords
cyclomarin
heptapeptide
inflammatory
inflammatory agent
isolated
Prior art date
Application number
FI963194A
Other languages
English (en)
Swedish (sv)
Other versions
FI963194A (fi
Inventor
William H Fenical
Robert S Jacobs
Paul R Jensen
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Publication of FI963194A0 publication Critical patent/FI963194A0/fi
Publication of FI963194A publication Critical patent/FI963194A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI963194A 1994-02-18 1996-08-15 Syklinen tulehduksenvastainen heptapeptidi FI963194A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/198,859 US5444043A (en) 1994-02-18 1994-02-18 Cyclic heptapeptide anti-inflammatory agent
PCT/US1995/001970 WO1995022339A1 (en) 1994-02-18 1995-02-16 Cyclic heptapeptide anti-inflammatory agent

Publications (2)

Publication Number Publication Date
FI963194A0 true FI963194A0 (fi) 1996-08-15
FI963194A FI963194A (fi) 1996-09-23

Family

ID=22735156

Family Applications (1)

Application Number Title Priority Date Filing Date
FI963194A FI963194A (fi) 1994-02-18 1996-08-15 Syklinen tulehduksenvastainen heptapeptidi

Country Status (15)

Country Link
US (2) US5444043A (fi)
EP (1) EP0744955B1 (fi)
JP (1) JPH09509318A (fi)
KR (1) KR100349485B1 (fi)
AT (1) ATE221385T1 (fi)
AU (1) AU696517B2 (fi)
BR (1) BR9506866A (fi)
CA (1) CA2181827A1 (fi)
CZ (1) CZ231896A3 (fi)
DE (1) DE69527610D1 (fi)
FI (1) FI963194A (fi)
HU (1) HU221122B1 (fi)
NO (1) NO963418L (fi)
NZ (1) NZ281823A (fi)
WO (1) WO1995022339A1 (fi)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5444043A (en) * 1994-02-18 1995-08-22 The Regents Of The University Of California Cyclic heptapeptide anti-inflammatory agent
US5759995A (en) * 1996-09-05 1998-06-02 Phytera, Inc. Antiviral treatment
DE60234057D1 (de) 2001-07-25 2009-11-26 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
EP2392258B1 (en) 2005-04-28 2014-10-08 Proteus Digital Health, Inc. Pharma-informatics system
WO2006119174A1 (en) * 2005-04-30 2006-11-09 Ocular Surface Center, P.A. Method for treating ocular demodex
US8795627B2 (en) 2007-03-21 2014-08-05 Raptor Pharmaceuticals Inc. Treatment of liver disorders by administration of RAP conjugates
US8128968B2 (en) * 2007-08-29 2012-03-06 Tissuetech, Inc. Compositions and methods for treating Demodex infestations
AU2010216512B2 (en) 2009-02-20 2016-06-30 2-Bbb Medicines B.V. Glutathione-based drug delivery system
WO2010129819A2 (en) 2009-05-06 2010-11-11 Laboratory Skin Care, Inc. Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
WO2018128826A1 (en) * 2017-01-06 2018-07-12 Cidara Therapeutics, Inc. Compositions and methods for the treatment of bacterial infections
WO2019126353A2 (en) * 2017-12-20 2019-06-27 Cidara Therapeutics, Inc. Compositions and methods for the treatment of bacterial infections
CN111647050B (zh) * 2020-05-13 2021-11-09 中国科学院南海海洋研究所 一种怡莱霉素f衍生物及其在制备抗结核分枝杆菌药物中的应用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE32455E (en) * 1978-10-16 1987-07-07 Eli Lilly And Company A-21978 antibiotics and process for their production
US4331594A (en) * 1978-10-16 1982-05-25 Eli Lilly And Company A-21978 Antibiotics and process for their production
CA1172980A (en) * 1979-04-02 1984-08-21 Kenji Takemoto Pentadecapeptide and process for the preparation thereof
US4950649A (en) * 1980-09-12 1990-08-21 University Of Illinois Didemnins and nordidemnins
US4342829A (en) * 1981-05-06 1982-08-03 Eli Lilly And Company Process for preparing narasin
US4384043A (en) * 1981-09-02 1983-05-17 American Cyanamid Company Process for producing the antibiotic nosiheptide
US4409210A (en) * 1982-01-15 1983-10-11 Bristol-Myers Company Antibiotic compound
US4677071A (en) * 1982-03-25 1987-06-30 American Cyanamid Company Antibiotic agents from S. coeruleorubidus, rubidus
US4608343A (en) * 1983-06-23 1986-08-26 American Cyanamid Company Biologically pure culture of Streptomyces majorciensis Labeda
US4582639A (en) * 1984-06-18 1986-04-15 Bristol-Myers Company Antitumor antibiotic compound
US4885243A (en) * 1984-10-09 1989-12-05 Eli Lilly And Company Process for producing A-21978C derivatives
US5006466A (en) * 1986-11-21 1991-04-09 Merck & Co., Inc. Fermentation analogs of virginiamycin M1
US5229362A (en) * 1986-12-15 1993-07-20 Eli Lilly And Company Antibiotic A10255 complex and factors, and process and production therefor
US5217952A (en) * 1988-02-02 1993-06-08 Fujisawa Pharmaceutical Co., Ltd. Peptides WS-9326a and WS-9326b, derivatives thereof and uses thereof
US5028590A (en) * 1988-04-11 1991-07-02 Eli Lilly And Company Derivatives of A54145 cyclic peptides
US4977083A (en) * 1988-04-11 1990-12-11 Eli Lilly And Company Processes for preparing A54145 compounds
US5138036A (en) * 1989-11-13 1992-08-11 Arizona Board Of Regents Acting On Behalf Of Arizona State University Isolation and structural elucidation of the cytostatic cyclodepsipeptide dolastatin 14
US5336757A (en) * 1992-02-07 1994-08-09 Harbor Branch Oceanographic Institution, Inc. Antibacterial peptide and methods of use
US5444043A (en) * 1994-02-18 1995-08-22 The Regents Of The University Of California Cyclic heptapeptide anti-inflammatory agent

Also Published As

Publication number Publication date
HU221122B1 (en) 2002-08-28
US5444043A (en) 1995-08-22
EP0744955B1 (en) 2002-07-31
NO963418L (no) 1996-08-15
AU696517B2 (en) 1998-09-10
EP0744955A1 (en) 1996-12-04
US5593960A (en) 1997-01-14
NZ281823A (en) 1997-11-24
CA2181827A1 (en) 1995-08-24
FI963194A (fi) 1996-09-23
WO1995022339A1 (en) 1995-08-24
KR100349485B1 (ko) 2002-11-18
HU9602252D0 (en) 1996-10-28
CZ231896A3 (en) 1997-01-15
BR9506866A (pt) 1997-09-09
HUT75832A (en) 1997-05-28
ATE221385T1 (de) 2002-08-15
DE69527610D1 (de) 2002-09-05
AU1877395A (en) 1995-09-04
EP0744955A4 (en) 1998-12-16
JPH09509318A (ja) 1997-09-22

Similar Documents

Publication Publication Date Title
FI963194A (fi) Syklinen tulehduksenvastainen heptapeptidi
ZA997767B (en) Method for producing L-amino acid.
FI991477A (fi) Menetelmä tolterodiinin valmistamiseksi
TR199701544T1 (xx) Yeni dolastatin t�revleri,bunlar�n haz�rlanmas� ve kullan�lmas�.
MX9702724A (es) Lipasa, microorganismo que la produce, procedimiento para la preparacion de dicha lipasa y su uso.
UA32566C2 (uk) Спосіб одержання штаму мікроорганізму, спосіб продукування триптофану
AU4091297A (en) Antiparasitic agents
CA2187250A1 (en) Method for Producing a Soluble Protein with Bacteria
KR920008193A (ko) 카르바스틴의 제조방법
DE69632407D1 (de) Antikörper gegen l-selectin zur vorbeugung von multiplem organversagen und akuter organschädigung
KR950700988A (ko) 미생물, 이들의 제조방법 및 이들의 사용(Micro-organisms, preparation method therefor and uses thereof)
JPS557001A (en) Preparation of n-carbamoyl-d-thienylglycine
ES2139341T3 (es) Isocomarinas antitumorales.
NO996401L (no) Fremgangsmõte for fremstilling av amider
ES480904A1 (es) Un procedimiento para la produccion del antibiotico mycopla-necin.
NZ511728A (en) Substances WK-5344A and WK-5344B obtained from microorganisms of the genus Streptomyces
DK1032580T3 (da) Fremgangsmåde til N-desmethylering af erythromyciner og derivater deraf
DE59107073D1 (de) Typ II-Restriktionsendonuklease Ssp4800I
ATE203922T1 (de) Abbau halogenierter kohlenwasserstoffe durch halophile archaea
JPS533593A (en) Preparation of gel-forming microbial protein
IT1276454B1 (it) Metodo per la diagnosi di infezioni helycobacter pylori e relativo corredo diagnostico.
KR930703456A (ko) 발효법에 의한 l-알라닌의 제조방법
KR920004284A (ko) 폐수 처리용 미생물 영양 조성물의 제조방법
RU2072690C1 (ru) Штамм бактерий morganella morganii - продуцент термолабильного энтеротоксина
KR930013091A (ko) 반코마이신을 생산하는 미생물